{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:18:40Z","timestamp":1770967120445,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jgar.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T23:00:51Z","timestamp":1500418851000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary\/recent or chronic HIV-infected over the period 2013\u20132016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors"],"prefix":"10.1016","volume":"10","author":[{"given":"Samantha","family":"Andreis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Scaggiante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicio","family":"Manfrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Panese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermenegildo","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Boldrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Dal Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Mengoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ombretta","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-0333","authenticated-orcid":false,"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-0068","authenticated-orcid":false,"given":"Saverio Giuseppe","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.05.011_bib0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 Recommendations of the International Antiviral Society-USA Panel","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2017.05.011_bib0010","unstructured":"European AIDS Clinical Society EACS guidelines version 8.0. Available at: http:\/\/www.eacsociety.org\/files\/guidelines_8_0-english_web.pdf. [Accessed 29 October 2015]."},{"key":"10.1016\/j.jgar.2017.05.011_bib0015","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/JCM.00056-07","article-title":"Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients","volume":"45","author":"Parisi","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2017.05.011_bib0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/01.aids.0000232246.36039.f0","article-title":"Drug resistance mutations can be archived very early in HIV primary infection","volume":"20","author":"Parisi","year":"2006","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2017.05.011_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/hiv.12236","article-title":"Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial","volume":"16","author":"Baxter","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.jgar.2017.05.011_bib0030","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Pham","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jgar.2017.05.011_bib0035","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/jac\/dkv120","article-title":"Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999\u20132011","volume":"70","author":"Buchacz","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","author":"Vercauteren","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2017.05.011_bib0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"Hofstra","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2017.05.011_bib0050","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2017.05.011_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000000831","article-title":"Prevalence of transmitted HIV drug resistance among recently infected persons in San Diego, CA 1996\u20132013","volume":"71","author":"Panichsillapakit","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jgar.2017.05.011_bib0060","doi-asserted-by":"crossref","first-page":"e0125837","DOI":"10.1371\/journal.pone.0125837","article-title":"Trends in transmission of drug resistance and prevalence of non-B subtypes in patients with acute or recent HIV-1 infection in Barcelona in the last 16 years (1997\u20132012)","volume":"10","author":"Ambrosioni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2017.05.011_bib0065","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/jac\/dkv049","article-title":"HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007\u201312: impact on susceptibility to first-line strategies","volume":"70","author":"Frange","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jgar.2013.05.008","article-title":"Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004\u20132012 in the Veneto Region, Italy","volume":"1","author":"Parisi","year":"2013","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2017.05.011_bib0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jgar.2015.07.006","article-title":"Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1","volume":"3","author":"Montagna","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2017.05.011_bib0080","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/jac\/dkv202","article-title":"Primary resistance to integrase strand-transfer inhibitors in Europe","volume":"70","author":"Casadell\u00e0","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0085","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/jac\/dkv243","article-title":"Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades","volume":"70","author":"Doyle","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/infdis\/jiw165","article-title":"Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study","volume":"214","author":"Scherrer","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2017.05.011_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkw376","article-title":"Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute\/recent HIV infection","volume":"72","author":"Ambrosioni","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0100","unstructured":"Stanford HIV drug resistance database. http:\/\/hivdb.stanford.edu. [Accessed 20 November 2016]."},{"key":"10.1016\/j.jgar.2017.05.011_bib0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"Web Server issue","key":"10.1016\/j.jgar.2017.05.011_bib0110","doi-asserted-by":"crossref","first-page":"W634","DOI":"10.1093\/nar\/gkp455","article-title":"A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences","volume":"37","author":"Alcantara","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgar.2017.05.011_bib0115","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"de Oliveira","year":"2005","journal-title":"Bioinfomatics"},{"key":"10.1016\/j.jgar.2017.05.011_bib0120","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/jac\/dkt238","article-title":"National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001\u20132011","volume":"68","author":"Descamps","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkm082","article-title":"Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection","volume":"59","author":"Booth","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3182618f05","article-title":"Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients","volume":"61","author":"Yanik","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jgar.2017.05.011_bib0135","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/jac\/dkr291","article-title":"Transmission dynamics of the M184V drug resistance mutation in primary HIV infection","volume":"66","author":"Wainberg","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"104","key":"10.1016\/j.jgar.2017.05.011_bib0140","first-page":"e1","article-title":"Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults","volume":"21","author":"Alvarez","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2017.05.011_bib0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jac\/dkt003","article-title":"Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses","volume":"68","author":"Lambert-Niclot","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.05.011_bib0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1468-1293.2010.00832.x","article-title":"Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades","volume":"11","author":"Lai","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jgar.2017.05.011_bib0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jviromet.2015.06.002","article-title":"Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation","volume":"222","author":"Ndiaye","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jgar.2017.05.011_bib0160","first-page":"150","article-title":"HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes","volume":"39","author":"Tatarelli","year":"2016","journal-title":"New Microbiol"},{"key":"10.1016\/j.jgar.2017.05.011_bib0165","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1017\/S0950268810000166","article-title":"Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications","volume":"138","author":"Torti","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2017.05.011_bib0170","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/QAD.0000000000000326","article-title":"High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response","volume":"28","author":"Pernas","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jgar.2017.05.011_bib0175","first-page":"1537","article-title":"Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation","volume":"72","author":"Jaffr\u00e9","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T17:12:13Z","timestamp":1569863533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651730098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"alternative-id":["S221371651730098X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.05.011","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary\/recent or chronic HIV-infected over the period 2013\u20132016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}